Decoding Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment.

Area of Science:

• Cardiovascular Medicine
• Pulmonary Medicine
• Vascular Biology

Background:

• Pulmonary embolism (PE) is a critical condition with high morbidity and mortality.
• PE pathogenesis involves endothelial dysfunction, pro-thrombotic states, inflammation, oxidative stress, and vascular remodeling.
• PE can lead to severe complications like recurrent thromboembolism, pulmonary hypertension, and heart failure.

Purpose of the Study:

• To provide a comprehensive overview of PE mechanisms and risk factors.
• To explore current diagnostic tools, risk stratification methods, and biomarkers for PE.
• To synthesize knowledge on enhanced PE management and prevention strategies.

Main Methods:

• Review of existing literature on PE.
• Analysis of underlying pathophysiological mechanisms.
• Evaluation of diagnostic tools, scoring systems, and biomarkers.
• Synthesis of current management and preventive strategies.

Main Results:

• PE involves complex endothelial dysfunction and vascular changes.
• Risk stratification and precise diagnosis are crucial for effective management.
• Both conventional and novel biomarkers show potential for PE diagnosis.
• Enhanced management and prevention strategies are evolving.

Conclusions:

• Accurate risk stratification and diagnosis are vital for improving PE outcomes.
• Further research is needed to enhance diagnostic accuracy and therapeutic efficacy for PE.
• A comprehensive approach to PE management, incorporating new strategies, is essential.